ENCell이엔셀
456070 · KOSDAQ · ₩456070 · 이엔셀
₩4,860▼ ₩170 (3.38%)End-of-day · Oct 29, 2026 · End-of-day prices.
Filings
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 27, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Aug 24, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Adjustment of Conversion Price (1st Series)전환가액의조정 (제1회차)Jul 13, 2026Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인) (샤르코마리투스(CharcotMarieTooth disease, CMT) 1A형 환자를 대상으로 EN001의 유효성 및 안전성을 평가하기 위해 1b/2a상 임상시험계획 변경승인)Jul 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 25, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 24, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 24, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 24, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 2, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Jun 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 20, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Major sales or supply contract단일판매ㆍ공급계약체결Apr 20, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Apr 15, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 2, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 2, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 30, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (근감소증 환자를 대상으로 EN001의 유효성 및 안전성 평가를 위한 다기관, 무작위배정, 이중눈가림, 위약대조 임상시험 계획 변경승인)Mar 20, 2026Open on DART
- Audit report submitted감사보고서제출Mar 20, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 20, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과)Mar 17, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 12, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 12, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 12, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Mar 11, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 11, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 11, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Mar 10, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 12, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (근감소증 환자를 대상으로 EN001의 유효성 및 안전성 평가를 위한 다기관, 무작위배정, 이중눈가림, 위약대조, 제1/2상 임상시험계획 변경승인신청)Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jan 14, 2026Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험결과) (샤르코마리투스(CharcotMarieTooth disease, CMT) 1A형 환자를 대상으로 EN001의 유효성 및 안전성을 평가하기 위해 1b상 임상시험의 임상1b상 Topline 결과 발표)Jan 8, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Dec 23, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(약식)Dec 15, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Dec 15, 2025Open on DART
- Results of Securities Issuance (Voluntary Disclosure) (1st Convertible Bonds)증권발행결과(자율공시) (제1회차 CB)Dec 12, 2025Open on DART
- Convertible bond issue decision주요사항보고서(전환사채권발행결정)Dec 4, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인) (샤르코마리투스(CharcotMarieTooth disease, CMT) 1A형 환자를 대상으로 EN001의 유효성 및 안전성을 평가하기 위해 1b/2a상 임상시험계획 변경승인)Nov 17, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 4, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 30, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Sep 22, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Sep 22, 2025Open on DART
- Investor relations (IR) event기업설명회(IR)개최Sep 15, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획변경승인신청) (샤르코마리투스(CharcotMarieTooth disease, CMT) 1A형 환자를 대상으로 EN001의 유효성 및 안전성을 평가하기 위해 1b/2a상 임상시험계획 변경승인을 신청)Aug 18, 2025Open on DART
- Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: ENCell / 이엔셀 / 456070 / KRX:456070
Source: KRX statistical information